Some longtime advocates of the therapy say they’re pessimistic about its future. This is a Kaiser Health News story. Six months after it was controversially hailed by Trump administration officials as ...

The recently identified Omicron variant is the cause behind a surge of coronavirus disease 2019 (COVID-19) cases and hospitalizations in the last few months of 2021. While Omicron infects both ...

The FDA’s withdrawal of its authorization for Evusheld, a monoclonal antibody therapy used to prevent and treat Covid-19, leaves no monoclonals available for this purpose. Another monoclonal, ...

A team of scientists from France has recently demonstrated the efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma therapy in improving the survival rate among patients with B-cell ...

Six months after it was controversially hailed by Trump administration officials as a “breakthrough” therapy to fight the worst effects of Covid-19, convalescent plasma appears to be on the ropes. The ...

A recent study has demonstrated that COVID-19 convalescent plasma treatment (or blood from individuals who have recovered from the disease) can slash the risk of hospitalization by over 50 percent.

On Sunday, Aug. 23, the U.S. Food and Drug Administration announced an emergency use authorization of convalescent plasma therapy to help treat COVID-19. An emergency use authorization from the FDA ...

A newly approved treatment with some history of success could offer hope for the sickest of the country’s COVID-19 patients. The U.S. Food and Drug Administration has approved the use of convalescent ...

Research shows that high-titer (antibody-rich) COVID convalescent plasma -- when administered to COVID-19 outpatients within nine days after testing positive -- reduced the need for hospitalization ...

Researchers found it helped patients when used early in an infection. Medical researchers say there is renewed promise in reducing COVID-19-related hospitalizations and deaths by increasing the use of ...

After encountering an infectious agent, the immune system begins churning out antibodies—Y-shaped warriors that neutralize pathogens—into the blood circulation. In theory, donor blood from patients ...

Research just released has cast doubt on whether plasma treatments can help seriously ill COVID-19 patients, suggesting that in fact they may produce "adverse" effects. The results of the study come ...